Cullen Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$15.2M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$7.74M |
| 3 |
Telefônica Brasil
VIV
|
+$3.17M |
| 4 |
Cardinal Health
CAH
|
+$2.61M |
| 5 |
ICICI Bank
IBN
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$45.5M |
| 2 |
ExxonMobil
XOM
|
+$18.5M |
| 3 |
BCE
BCE
|
+$14.1M |
| 4 |
AT&T
T
|
+$12.5M |
| 5 |
Johnson Controls International
JCI
|
+$9.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.41% |
| 2 | Financials | 14.13% |
| 3 | Consumer Staples | 11.14% |
| 4 | Technology | 9.88% |
| 5 | Energy | 9.78% |
Similar funds
Cullen Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Cullen Capital Management held 132 positions worth $2.32B, down 15% from $2.71B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Cullen Capital Management withdrew a net $169M in Q4 2018, closing 4 positions and reducing 70 holdings. Its most notable exit was Novo Nordisk, an estimated $2.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Cullen Capital Management opened a new position in Cardinal Health worth $2.23M.
- Cullen Capital Management's largest Q4 2018 buy was Cardinal Health: 50,030 shares worth $2.23M.
- Cullen Capital Management added most to DuPont de Nemours in Q4 2018, an estimated $15.2M increase.
- Cullen Capital Management's biggest Q4 2018 reduction was MetLife, cutting an estimated $45.5M.
- Cullen Capital Management fully exited Novo Nordisk in Q4 2018, selling an estimated $2.81M.
- Cullen Capital Management's ten largest holdings make up 31% of its $2.32B portfolio in Q4 2018.
- Cullen Capital Management opened 4 new positions and closed 4 in Q4 2018.
- Cullen Capital Management's portfolio value fell 15% quarter-over-quarter to $2.32B.
Based on Cullen Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.